These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 3092086)

  • 1. The effects of cannabis use on the clinical condition of schizophrenics.
    Negrete JC; Knapp WP
    NIDA Res Monogr; 1986; 67():321-7. PubMed ID: 3092086
    [No Abstract]   [Full Text] [Related]  

  • 2. Cannabis use and neuropsychological performance in healthy individuals and patients with schizophrenia.
    Scholes KE; Martin-Iverson MT
    Psychol Med; 2010 Oct; 40(10):1635-46. PubMed ID: 20018124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabis abuse is associated with decision-making impairment among first-episode patients with schizophrenia-spectrum psychosis.
    Mata I; Rodríguez-Sánchez JM; Pelayo-Terán JM; Pérez-Iglesias R; González-Blanch C; Ramírez-Bonilla M; Martínez-García O; Vázquez-Barquero JL; Crespo-Facorro B
    Psychol Med; 2008 Sep; 38(9):1257-66. PubMed ID: 18005495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of cannabis abuse on the symptoms of schizophrenia: patient perspectives.
    Costain WF
    Int J Ment Health Nurs; 2008 Aug; 17(4):227-35. PubMed ID: 18666905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain-derived neurotrophic factor serum concentrations are increased in drug-naive schizophrenic patients with chronic cannabis abuse and multiple substance abuse.
    Jockers-Scherübl MC; Danker-Hopfe H; Mahlberg R; Selig F; Rentzsch J; Schürer F; Lang UE; Hellweg R
    Neurosci Lett; 2004 Nov; 371(1):79-83. PubMed ID: 15500971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabis use and premorbid functioning as predictors of poorer neurocognition in schizophrenia spectrum disorder.
    Ringen PA; Melle I; Berg AO; Agartz I; Spigset O; Simonsen C; Sundet K; Andreassen OA
    Schizophr Res; 2013 Jan; 143(1):84-9. PubMed ID: 23178107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reasons for cannabis use: patients with schizophrenia versus matched healthy controls.
    Schaub M; Fanghaenel K; Stohler R
    Aust N Z J Psychiatry; 2008 Dec; 42(12):1060-5. PubMed ID: 19016094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabis abuse in patients with schizophrenia: pattern and effects on symptomatology.
    Rehman IU; Farooq S
    J Coll Physicians Surg Pak; 2007 Mar; 17(3):158-61. PubMed ID: 17374302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabis use and schizophrenia.
    Krebs MO; Goldberger C; Dervaux A
    Am J Psychiatry; 2005 Feb; 162(2):401-2; author reply 402. PubMed ID: 15677615
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical features of cannabis psychosis in schizophrenia patients].
    Kenchadze VG; Chkoniia ED
    Georgian Med News; 2006 Aug; (137):55-8. PubMed ID: 16980745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabis induces different cognitive changes in schizophrenic patients and in healthy controls.
    Jockers-Scherübl MC; Wolf T; Radzei N; Schlattmann P; Rentzsch J; Gómez-Carrillo de Castro A; Kühl KP
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1054-63. PubMed ID: 17482741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adequate antipsychotic treatment normalizes serum nerve growth factor concentrations in schizophrenia with and without cannabis or additional substance abuse.
    Jockers-Scherübl MC; Rentzsch J; Danker-Hopfe H; Radzei N; Schürer F; Bahri S; Hellweg R
    Neurosci Lett; 2006 Jun; 400(3):262-6. PubMed ID: 16540246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lifetime positive symptoms in patients with schizophrenia and cannabis abuse are partially explained by co-morbid addiction.
    Dubertret C; Bidard I; Adès J; Gorwood P
    Schizophr Res; 2006 Sep; 86(1-3):284-90. PubMed ID: 16806837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabis affects the severity of schizophrenic symptoms: results of a clinical survey.
    Negrete JC; Knapp WP; Douglas DE; Smith WB
    Psychol Med; 1986 Aug; 16(3):515-20. PubMed ID: 3489951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drawing conclusions about cannabis and psychosis.
    Castle D
    Psychol Med; 2008 Mar; 38(3):459-60; author reply 462-4. PubMed ID: 18298876
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of cannabis use on the course of schizophrenia in male patients: a prospective cohort study.
    van Dijk D; Koeter MW; Hijman R; Kahn RS; van den Brink W
    Schizophr Res; 2012 May; 137(1-3):50-7. PubMed ID: 22313726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schizophrenia and cannabis use.
    Kumra S
    Minn Med; 2007 Jan; 90(1):36-8. PubMed ID: 17305103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabis use and schizophrenia.
    Wade D
    Am J Psychiatry; 2005 Feb; 162(2):401; author reply 402. PubMed ID: 15677616
    [No Abstract]   [Full Text] [Related]  

  • 19. Differential effects of chronic cannabis use on preattentional cognitive functioning in abstinent schizophrenic patients and healthy subjects.
    Rentzsch J; Buntebart E; Stadelmeier A; Gallinat J; Jockers-Scherübl MC
    Schizophr Res; 2011 Aug; 130(1-3):222-7. PubMed ID: 21624823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabis and schizophrenia: impact on onset, course, psychopathology and outcomes.
    Bersani G; Orlandi V; Kotzalidis GD; Pancheri P
    Eur Arch Psychiatry Clin Neurosci; 2002 Apr; 252(2):86-92. PubMed ID: 12111342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.